PROFUSA, INC. Shareholders' Equity
PROFUSA, INC. (PFSA) had Shareholders' Equity of -$27.13 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-19
- 2026-06-30: Stockholders' Equity Attributable to Parent -$27.13M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$28.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$26.66M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$33.96M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$27.13M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | -$28.20M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | -$26.66M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | -$33.96M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | -$124.18M 10-Q · filed 2026-08-19 | -$22.51M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$121.92M 10-Q · filed 2026-08-19 | -$14.30M 10-Q · filed 2025-06-13 |
| 2024-12-31 | -$119.20M 10-Q · filed 2026-08-19 | -$12.96M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$116.96M 10-Q · filed 2025-11-19 | -$5.18M 10-Q · filed 2024-12-17 |
| 2024-06-30 | -$114.47M 10-Q · filed 2025-11-19 | -$5.08M 10-Q · filed 2024-11-15 |
| 2024-03-31 | -$112.06M 10-Q · filed 2025-11-19 | -$4.50M 10-Q · filed 2024-10-09 |
| 2023-12-31 | -$110.00M S-1/A · filed 2026-05-01 | -$3.46M 10-K · filed 2024-02-26 |
| 2023-09-30 | -$3.48M 10-Q · filed 2024-12-17 | |
| 2023-06-30 | -$2.87M 10-Q · filed 2024-12-17 | |
| 2023-03-31 | -$3.31M 10-Q · filed 2024-12-17 | |
| 2022-12-31 | -$619.48K 10-K · filed 2025-03-31 | |
| 2022-09-30 | -$373.86K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | -$1.12M 10-Q · filed 2023-11-20 | |
| 2022-03-31 | -$2.20M 10-Q · filed 2023-11-20 | |
| 2021-12-31 | -$5.91M 10-K · filed 2024-02-26 | |
| 2021-09-30 | $24.66K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $24.66K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |